liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Synthesis and Characterization of Novel Fluoro-glycosylated Porphyrins that can be Utilized as Theranostic Agents
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, Faculty of Science & Engineering.
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, Faculty of Science & Engineering.
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, Faculty of Science & Engineering.
Linköping University, Department of Physics, Chemistry and Biology, Chemistry. Linköping University, Faculty of Science & Engineering.
Show others and affiliations
2018 (English)In: ChemistryOpen, ISSN 2191-1363, Vol. 7, no 7, p. 495-503Article in journal (Refereed) Published
Abstract [en]

Small molecules with modalities for a variety of imaging techniques as well as therapeutic activity are essential, as such molecules render opportunities to simultaneously conduct diagnosis and targeted therapy, so called theranostics. In this regard, glycoporphyrins have proven useful as theranostic agents towards cancer, as well as noncancerous conditions. Herein, the synthesis and characterization of heterobifunctional glycoconjugated porphyrins with two different sugar moieties, a common monosaccharide at three sites, and a 2-fluoro-2-deoxy glucose (FDG) moiety at the fourth site are presented. The fluoro-glycoconjugated porphyrins exhibit properties for multimodal imaging and photodynamic therapy, as well as specificity towards cancer cells. We foresee that our findings might aid in the chemical design of heterobifunctional glycoconjugated porphyrins that could be utilized as theranostic agents.

Place, publisher, year, edition, pages
Wiley-VCH Verlagsgesellschaft, 2018. Vol. 7, no 7, p. 495-503
Keywords [en]
cancer; glycoporphyrins; imaging; photodynamic therapy; photosensitizers
National Category
Medicinal Chemistry
Identifiers
URN: urn:nbn:se:liu:diva-150279DOI: 10.1002/open.201800020ISI: 000440286200002PubMedID: 30003003Scopus ID: 2-s2.0-85051290816OAI: oai:DiVA.org:liu-150279DiVA, id: diva2:1239704
Note

Funding Agencies|Swedish Foundation for Strategic Research; Swedish Research Council

Available from: 2018-08-17 Created: 2018-08-17 Last updated: 2019-04-01Bibliographically approved
In thesis
1. Multimodal Porphyrin-Based Conjugates: Synthesis and characterization for applications as amyloid ligands, photodynamic therapy agents and chiroptical materials
Open this publication in new window or tab >>Multimodal Porphyrin-Based Conjugates: Synthesis and characterization for applications as amyloid ligands, photodynamic therapy agents and chiroptical materials
2018 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Organic compounds that interact both with certain biological targets and display specific photophysical properties can be utilized as molecular tools to visualize and possibly effect disease related processes taking place in living organisms. In this regard, porphyrins are a class of naturally occurring molecules that possess intriguingly interesting photophysical properties where they can act as luminescent probes by emitting detectable light, as well as photosensitizers in the light mediated therapy called photodynamic therapy. In this thesis, the porphyrin structure has been synthetically combined with other molecule classes to achieve compounds with desirable multimodal characteristics.

Firstly, luminescent conjugated oligothiophenes (LCOs) that have extensively, and with great success, been utilized as fluorescent ligands for amyloid formations, have been conjugated to porphyrins to render oligothiophene porphyrin hybrids (OTPHs) comprising two optically active modalities. When applied as fluorescent amyloidophilic dyes for visualization of amyloid-β (Aβ), one of the pathological hallmarks in Alzheimer’s disease, an enhanced optical assignment of distinct aggregated forms of Aβ was afforded.  Thus, properly functionalized OTPHs could give us more information about pathological processes underlying devastating disorders, such as Alzheimer’s disease. In addition, the OTPHs can be associated with synthetic peptides inducing peptide folding into certain three-dimensional helical structures giving rise to novel optically active materials.

Secondly, this thesis also embraces porphyrins’ potential as photosensitizers in photodynamic therapy to kill cancer cells. Grounded on the prerequisites for an optimal photosensitizer, we designed porphyrin-based conjugates equipped with common carbohydrates for improved cancer cell selectivity and with a fluorinated glucose derivative, 2-fluoro 2-deoxy glucose, for advantageous metabolism in cancer cells. Furthermore, incorporation of a radioisotopic fluorine-18 atom into the glycoporphyrins could give the means for diagnostic use of the conjugates in positron emission tomography (PET).

In order to tether together the above-mentioned molecular moieties in a controlled fashion, we developed a robust synthetic strategy for asymmetrical functionalization of porphyrin core. The method involves chlorosulfonation of this otherwise inert tetrapyrrolic structure, followed by alkynylation. Parallelly to amide coupling reactions, copper(I)-catalyzed alkyne azide cycloaddition is used for fast and high-yielding late-stage conjugations. Overall, this thesis demonstrates how combining different molecular moieties in synthetic organic chemistry yields novel molecules with combined and improved multimodal properties for biological and medicinal applications, guided by the design-by-function methodology.      

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2018. p. 83
Series
Linköping Studies in Science and Technology. Dissertations, ISSN 0345-7524 ; 1947
National Category
Organic Chemistry
Identifiers
urn:nbn:se:liu:diva-150522 (URN)10.3384/diss.diva-150522 (DOI)9789176852552 (ISBN)
Public defence
2018-11-09, Planck, Fysikhuset, Campus Valla, Linköping, 09:15 (Swedish)
Opponent
Supervisors
Available from: 2018-08-27 Created: 2018-08-24 Last updated: 2019-09-26Bibliographically approved

Open Access in DiVA

fulltext(1595 kB)68 downloads
File information
File name FULLTEXT01.pdfFile size 1595 kBChecksum SHA-512
562a338e11a561ddd9280c52c77114dca9daff670fb7a1cf14cbef3ecc2f29fd82aecb803728cb84e33fee555c4b2e96642ebcbf5a422e9d46b1a87668086afd
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopusLink to Cover Profile

Search in DiVA

By author/editor
Arja, KatriannElgland, MathiasAppelqvist, HannaKonradsson, PeterNilsson, Peter
By organisation
ChemistryFaculty of Science & Engineering
In the same journal
ChemistryOpen
Medicinal Chemistry

Search outside of DiVA

GoogleGoogle Scholar
Total: 68 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 430 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf